307 related articles for article (PubMed ID: 27524217)
1. The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome.
Berger BE
Am J Med Sci; 2016 Aug; 352(2):177-90. PubMed ID: 27524217
[TBL] [Abstract][Full Text] [Related]
2. Atypical hemolytic uremic syndrome: a syndrome in need of clarity.
Berger BE
Clin Kidney J; 2019 Jun; 12(3):338-347. PubMed ID: 31198222
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
4. Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.
Hossain MA; Cheema A; Kalathil S; Bajwa R; Costanzo EJ; Cosentino J; Cheng J; Vachharajani T; Asif A
Saudi J Kidney Dis Transpl; 2018; 29(2):276-283. PubMed ID: 29657193
[TBL] [Abstract][Full Text] [Related]
5. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
Cataland SR; Wu HM
Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
[TBL] [Abstract][Full Text] [Related]
6. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
[TBL] [Abstract][Full Text] [Related]
7. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
Kistler AD
Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
[TBL] [Abstract][Full Text] [Related]
8. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
[TBL] [Abstract][Full Text] [Related]
9. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
[TBL] [Abstract][Full Text] [Related]
10. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
Sridharan M; Go RS; Willrich MAV
J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
[TBL] [Abstract][Full Text] [Related]
11. Atypical hemolytic uremic syndrome: from diagnosis to treatment.
Franchini M
Clin Chem Lab Med; 2015 Oct; 53(11):1679-88. PubMed ID: 25803082
[TBL] [Abstract][Full Text] [Related]
12. [Atypical hemolytic uremic syndrome].
Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura.
Oh J; Oh D; Lee SJ; Kim JO; Kim NK; Chong SY; Huh JY; Baker RI;
Blood Res; 2019 Sep; 54(3):218-228. PubMed ID: 31730685
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
15. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
Asif A; Nayer A; Haas CS
J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
[TBL] [Abstract][Full Text] [Related]
16. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
Laurence J
Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
[TBL] [Abstract][Full Text] [Related]
17. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.
Yoshida Y; Miyata T; Matsumoto M; Shirotani-Ikejima H; Uchida Y; Ohyama Y; Kokubo T; Fujimura Y
PLoS One; 2015; 10(5):e0124655. PubMed ID: 25951460
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
Cataland SR; Holers VM; Geyer S; Yang S; Wu HM
Blood; 2014 Jun; 123(24):3733-8. PubMed ID: 24695849
[TBL] [Abstract][Full Text] [Related]
19. [Atypical hemolytic uremic syndrome caused by primary complement defects].
Reusz G
Orv Hetil; 2018 Jun; 159(23):929-936. PubMed ID: 29860884
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
Sperati CJ; Moliterno AR
Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
